Publikationen, an denen er mitarbeitet Francisco Abad Santos (4)

2023

  1. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

2022

  1. First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135

2019

  1. A Neutrophil Timer Coordinates Immune Defense and Vascular Protection

    Immunity, Vol. 50, Núm. 2, pp. 390-402.e10

  2. Erratum: “A Neutrophil Timer Coordinates Immune Defense and Vascular Protection” (Immunity (2019) 50(2) (390–402.e10), (S1074761319300020), (10.1016/j.immuni.2019.01.002))

    Immunity